Company Overview
American HealthCare Capital is pleased to exclusively present a digital dental laboratory opportunity. The Company was established in the mid-2000s as a digital scanning laboratory primarily focused on modern dentistry technology related to the rising popularity of dental implants as a tooth replacement option. What started as a tech-driven project has evolved into a thriving enterprise, offering a comprehensive suite of digital products, advanced treatment planning solutions, and a wealth of educational resources curated by dentists for dentists.
In 2020, a group of visionary investors recognized the potential in the company’s vision and joined their venture. Together, they’ve been on an incredible journey of growth and innovation, driven by a shared passion for transforming the dental industry. The company’s commitment to progress led them to explore the world of AI software for treatment planning, expanding their offerings to include full arch surgical guides, particularly for cases involving toothless patients. Beyond products, they have launched a training academy, approved by the American Academy of General Dentistry-Pace, serving as both an educational hub and a valuable resource for dentists seeking to stay ahead in the ever-evolving technological landscape.
The Company’s commitment to progress led them to explore the world of AI software for treatment planning, expanding their offerings to include full arch surgical guides, particularly for cases involving toothless patients. Beyond products, they have launched a training academy, approved by the American Academy of General Dentistry-Pace, serving as both an educational hub and a valuable resource for dentists seeking to stay ahead in the ever-evolving technological landscape.
Financial Overview
The Company business model thrives on custom orders from licensed dentists and a subscription model that ensures recurring revenues. Despite the challenges of the pandemic, gross revenues have remained strong, ranging between $3 million and $4 million since 2019 with a net income margin of approximately 20%. The company successfully navigated through capital expenditures in 2022 in preparation for future growth, resulting in a lower-than-usual EBITDA. However, the Company is on track to finish 2024 with around $700,000 in adjusted EBITDA.
Asking Price
The present owners/investors, who have played a major role, of this business are extending an invitation for collaboration. Whether it’s through a joint-venture model or a majority stake acquisition, they’re seeking the right partner to amplify the current success and explore new horizons together
